Viewing Study NCT03176459


Ignite Creation Date: 2025-12-24 @ 3:05 PM
Ignite Modification Date: 2026-02-22 @ 4:52 PM
Study NCT ID: NCT03176459
Status: COMPLETED
Last Update Posted: 2021-01-06
First Post: 2017-05-31
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Evaluate the Safety and Efficacy of EXPAREL When Administered Via Infiltration Into the TAP vs. Bupivacaine Alone in Subjects Undergoing Elective C-Sections
Sponsor: Pacira Pharmaceuticals, Inc
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None C-Section View
None Pain Management View
Keywords:

Keywords

Keyword Brief Keyword Text View
None bupivacaine View
None exparel View
None analgesic View
None TAP Block View